Simplex Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,800
| Closed | -$274K | – | 9232 |
|
|
2026
Q1 | $274K | Sell |
6,800
-37,500
| -85% | -$808K | ﹤0.01% | 3923 |
|
|
2025
Q4 | $1.11M | Sell |
44,300
-100
| -0.2% | -$2.35K | ﹤0.01% | 2527 |
|
|
2025
Q3 | $1M | Buy |
44,400
+5,700
| +15% | +$133K | ﹤0.01% | 3042 |
|
|
2025
Q2 | $669K | Sell |
38,700
-9,800
| -20% | -$181K | ﹤0.01% | 3200 |
|
|
2025
Q1 | $1.06M | Buy |
48,500
+5,300
| +12% | +$146K | ﹤0.01% | 2657 |
|
|
2024
Q4 | $1.38M | Sell |
43,200
-61,300
| -59% | -$1.84M | ﹤0.01% | 2542 |
|
|
2024
Q3 | $3.01M | Buy |
104,500
+51,100
| +96% | +$1.89M | ﹤0.01% | 1917 |
|
|
2024
Q2 | $2.05M | Sell |
53,400
-15,300
| -22% | -$693K | ﹤0.01% | 2182 |
|
|
2024
Q1 | $4.04M | Sell |
68,700
-48,100
| -41% | -$3.07M | ﹤0.01% | 1769 |
|
|
2023
Q4 | $6.99M | Sell |
116,800
-106,900
| -48% | -$5.42M | ﹤0.01% | 1329 |
|
|
2023
Q3 | $8.51M | Buy |
223,700
+23,200
| +12% | +$1.02M | 0.01% | 1005 |
|
|
2023
Q2 | $18.3M | Buy |
200,500
+93,000
| +87% | +$8.02M | 0.02% | 624 |
|
|
2023
Q1 | $7.09M | Buy |
107,500
+45,700
| +74% | +$2.64M | 0.01% | 1082 |
|
|
2022
Q4 | $3.19M | Sell |
61,800
-3,900
| -6% | -$207K | ﹤0.01% | 1517 |
|
|
2022
Q3 | $4.49M | Buy |
65,700
+47,700
| +265% | +$2.82M | 0.01% | 1275 |
|
|
2022
Q2 | $813K | Sell |
18,000
-17,000
| -49% | -$775K | ﹤0.01% | 2854 |
|
|
2022
Q1 | $1.78M | Buy |
35,000
+32,000
| +1,067% | +$1.41M | ﹤0.01% | 2231 |
|
|
2021
Q4 | $141K | Sell |
3,000
-2,100
| -41% | -$82.7K | ﹤0.01% | 5695 |
|
|
2021
Q3 | $345K | Buy |
5,100
+100
| +2% | +$5.62K | ﹤0.01% | 4683 |
|
|
2021
Q2 | $316K | Buy |
5,000
+4,923
| +6,394% | +$254K | ﹤0.01% | 4884 |
|
|
2021
Q1 | $330K | Buy |
+77
| New | +$3.64K | ﹤0.01% | 4022 |
|
|
2020
Q3 | – | Sell |
-166
| Closed | -$542K | – | 7733 |
|
|
2020
Q2 | $542K | Sell |
166
-190
| -53% | -$6.1K | ﹤0.01% | 2793 |
|
|
2020
Q1 | $953K | Buy |
356
+145
| +69% | +$5.15K | ﹤0.01% | 1928 |
|
|
2019
Q4 | $646K | Buy |
211
+191
| +955% | +$5.29K | ﹤0.01% | 2494 |
|
|
2019
Q3 | $48K | Buy |
+20
| New | +$550 | ﹤0.01% | 5047 |
|
Other funds holding APLS
Simplex Trading's APLS Position: Q2 2026 in Review
Simplex Trading sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 2,735 shares — an estimated $110K sold.
Simplex Trading first reported a position in APLS in Q2 2019 and held it in 19 quarters. The position peaked at $6.92M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Simplex Trading reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 2,735 Apellis Pharmaceuticals shares in Q2 2026, an estimated $110K.
- Simplex Trading first reported a position in Apellis Pharmaceuticals in Q2 2019 and held it in 19 quarters.
- Simplex Trading's Apellis Pharmaceuticals position peaked at $6.92M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.